前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：202202233902899340 整理番号：22A0908316

COVID-19(CATALYST)の入院患者におけるケア基準と比較したナミルマブまたはインフリキシマブ: 無作為化,多施設,マルチアーム,多段,非盲検,適応,第2相,実証試験【JST・京大機械翻訳】

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

著者 (37件)：

Fisher Benjamin A

(Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK)

Fisher Benjamin A

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Fisher Benjamin A

(National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Veenith Tonny

(Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK)

Veenith Tonny

(Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Slade Daniel

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Gaskell Charlotte

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Rowland Matthew

(Kadoorie Centre for Critical Care Research, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK)

Whitehouse Tony

(Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK)

Whitehouse Tony

(Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Scriven James

(Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK)

Scriven James

(Department of Infectious Diseases, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Parekh Dhruv

(Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK)

Parekh Dhruv

(Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Parekh Dhruv

(Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Balasubramaniam Madhu S

(Department of Critical Care Medicine, Royal Bolton Hospital, Bolton, UK)

Cooke Graham

(Department of Infectious Disease, Imperial College London, London, UK)

Morley Nick

(Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK)

Gabriel Zoe

(Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK)

Wise Matthew P

(Department of Critical Care Medicine, University Hospital of Wales, Cardiff, UK)

Porter Joanna

(Department of Respiratory Medicine, University College Hospital, London, UK)

McShane Helen

(Jenner Institute, University of Oxford, Oxford, UK)

Ho Ling-Pei

(Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK)

Ho Ling-Pei

(Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK)

Newsome Philip N

(Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK)

Newsome Philip N

(National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Rowe Anna

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Rowe Anna

(National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Sharpe Rowena

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Thickett David R

(Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK)

Thickett David R

(Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Bion Julian

(Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK)

Bion Julian

(Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

Gates Simon

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Richards Duncan

(Oxford Clinical Trials Research Unit, Botnar Research Centre, University of Oxford, Oxford, UK)

Kearns Pamela

(Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)

Kearns Pamela

(National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK)

資料名：

Lancet Respiratory Medicine (Lancet Respiratory Medicine)

巻： 10 号： 3 ページ： 255-266 発行年： 2022年
JST資料番号： W3111A ISSN： 2213-2600 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：オランダ (NLD) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM